Stephen C. Farrell, Director at BIOTIME INC (BTX), bought 50,000 shares at $3.83 ($192K) on 2015-11-06, disclosed to the SEC on 2015-11-10.
Open-market purchase of $192k BTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| QCOR | SELL | 2014-06-04 | $337K | — | Filing → |
| QCOR | SELL | 2014-04-07 | $814K | — | Filing → |
| QCOR | SELL | 2014-03-11 | $326K | — | Filing → |